VanEck Pharmaceutical ETF $PPH Stock Position Trimmed by AAFMAA Wealth Management & Trust LLC

AAFMAA Wealth Management & Trust LLC cut its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 6.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 39,081 shares of the company’s stock after selling 2,875 shares during the quarter. VanEck Pharmaceutical ETF comprises 1.4% of AAFMAA Wealth Management & Trust LLC’s holdings, making the stock its 14th biggest position. AAFMAA Wealth Management & Trust LLC owned approximately 0.64% of VanEck Pharmaceutical ETF worth $3,438,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of PPH. Adamsbrown Wealth Consultants LLC lifted its position in VanEck Pharmaceutical ETF by 16.9% in the 1st quarter. Adamsbrown Wealth Consultants LLC now owns 174,902 shares of the company’s stock valued at $15,939,000 after purchasing an additional 25,271 shares during the last quarter. Royal Bank of Canada lifted its position in VanEck Pharmaceutical ETF by 53.3% in the 1st quarter. Royal Bank of Canada now owns 67,596 shares of the company’s stock valued at $6,160,000 after purchasing an additional 23,491 shares during the last quarter. Fluent Financial LLC bought a new stake in VanEck Pharmaceutical ETF in the 1st quarter valued at about $1,542,000. Canton Hathaway LLC bought a new stake in VanEck Pharmaceutical ETF in the 1st quarter valued at about $911,000. Finally, Dynamic Advisor Solutions LLC bought a new stake in VanEck Pharmaceutical ETF in the 1st quarter valued at about $679,000.

VanEck Pharmaceutical ETF Trading Down 2.3%

PPH stock opened at $85.99 on Friday. VanEck Pharmaceutical ETF has a 52 week low of $77.67 and a 52 week high of $95.43. The company has a market capitalization of $467.79 million, a price-to-earnings ratio of 20.21 and a beta of 0.72. The firm’s 50-day moving average is $87.47 and its two-hundred day moving average is $87.55.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, July 7th. Shareholders of record on Tuesday, July 1st were given a dividend of $0.6069 per share. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.52. The ex-dividend date was Tuesday, July 1st. This represents a $2.43 dividend on an annualized basis and a dividend yield of 2.8%.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.